Back to MNPR

GOLDMAN SACHS GROUP INC → MNPR

GOLDMAN SACHS GROUP INC MNPR Position History

Monopar Therapeutics Inc. • Healthcare

Quarters held
12
Latest value
$807K
Q3 2026
Peak value
$6.2M
First seen
Q1 2025

Dollar value over time

Show data table
PeriodPosition value
Q1 2025$673K
Q3 2025$533K
Q4 2025$454K
Q4 2025$223K
Q4 2025$223K
Q4 2025$454K
Q1 2026$1.6M
Q1 2026$261K
Q2 2026$738K
Q2 2026$758K
Q3 2026$6.2M
Q3 2026$807K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$807K10.1K——
Q3 2026$6.2M77.7K——
Q2 2026$758K8.2K——
Q2 2026$738K8.0K——
Q1 2026$261K4.8K——
Q1 2026$1.6M29.9K——
Q4 2025$454K7.0K——
Q4 2025$223K3.4K——
Q4 2025$223K3.4K——
Q4 2025$454K7.0K——
Q3 2025$533K6.5K——
Q1 2025$673K18.5K——

Other funds holding MNPR

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$37B
AAPL

APPLE INC

$31.7B
NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B